The first full regulatory approval for an amyloid-targeting therapy for Alzheimer’s disease could come within a month, after an expert panel voted 6 to 0 in favour of Eisai and Biogen’s Leqembi. The ...
A Redditor’s Monarch tool makes multi‑monitor switching on Windows 11 effortless, solving a headache Microsoft has yet to fix ...
Our '7 Days' weekly tech roundup brings the juiciest announcements. Read about fake Windows PC deals, WhatsApp passwords, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results